NYSE:TMO

Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts

Thermo Fisher Scientific Inc. (NYSE: TMO) is ending 2025 in the spotlight. As of Tuesday, December 2, 2025, Thermo Fisher Scientific stock is trading around $580 per share, slightly lower on the day but still near the top of its

2 December 2025

Thermo Fisher Scientific (TMO) Stock on 1 December 2025: HSBC Upgrade, Insider Moves, Buyback and 2026–2030 Forecasts

Thermo Fisher Scientific Inc. (NYSE: TMO), one of the world’s largest life sciences and diagnostics companies, is closing out 2025 with a flurry of news that matters for shareholders: a fresh analyst upgrade, new insider transactions, big institutional flows, a

1 December 2025

Company Analysis · Financial Forecasts · Insider Trading · Investments · NYSE:TMO · Stock Market

Thermo Fisher Scientific (TMO) Stock News Today: Insider Selling, Institutional Buying and New Growth Moves – November 28, 2025

Thermo Fisher Scientific Inc. (NYSE: TMO) stayed in the spotlight on November 28, 2025, with a cluster of headlines ranging from insider selling and fresh institutional stakes to new product launches and operational updates that could shape the stock’s medium‑term

29 November 2025

Company News · Insider Trading · Institutional Investors · Investment Strategies · NYSE:TMO · Stock Market

Thermo Fisher Stock Skyrockets – Biotech Boom & Big Deals Fuel Rally, Analysts Eye $650

Stock Performance and Sector Rally Thermo Fisher’s stock price has surged in recent weeks on renewed investor optimism. After a slow start to 2025 (even a ~10% year-over-year dip early in the year), the stock turned higher in October. TS2.Tech

22 October 2025

Analyst Insights · Biotech · Financial News · Investing · NYSE:TMO · Stock Market

Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

Market Overview Index Performance The 1 October 2025 session began under a cloud as the federal government shut down due to a budget impasse. Stock futures opened lower amid fears that key economic reports might be delayed investopedia.com. By the closing bell,

1 October 2025

Economic News · Financial Trends · Investment Insights · Market Analysis · NASDAQ:AZN · NASDAQ:BIIB · NYSE:LLY · NYSE:PFE · NYSE:TMO · Stock Market

Biotech & Health Bombshells: FDA Greenlights, Clinical Breakthroughs & Global Health Milestones (Aug 8–9, 2025)

Drug Approvals & Regulatory Developments (In Europe, regulators also made news: the EMA’s committee recommended approving darolutamide (Bayer’s Nubeqa) with hormone therapy for metastatic prostate cancer based on positive Phase 3 data onclive.com.) Clinical Trials & Research Breakthroughs Public Health

9 August 2025

Biotechnology · FDA Approvals · Global Health · Healthcare News · Medical Innovations · NASDAQ:BLUE · NYSE:TMO

Beyond the Eyepiece: The Next-Gen Microscopes of 2025–2026 Revolutionizing How We See the World

In March 2025 Zeiss introduced Lightfield 4D, integrated into the LSM 910 and 990 laser-scanning confocal microscopes, enabling instant volumetric imaging at up to 80 volume stacks per second and adding the Microscopy Copilot AI assistant. In May 2025 Leica

31 July 2025

Future Tech · Innovation · Microscopes · NYSE:TMO · Science · Technology

NYSE:TMO News 31 July 2025 - 2 December 2025